Literature DB >> 14635104

Auditory neuropathy in patients carrying mutations in the otoferlin gene (OTOF).

Montserrat Rodríguez-Ballesteros1, Francisco J del Castillo, Yolanda Martín, Miguel A Moreno-Pelayo, Constantino Morera, Félix Prieto, Jaime Marco, Antonio Morant, Jaime Gallo-Terán, Carmelo Morales-Angulo, Cristina Navas, Germán Trinidad, M Cruz Tapia, Felipe Moreno, Ignacio del Castillo.   

Abstract

Inherited hearing impairment affects one in 2,000 newborns. Nonsyndromic prelingual forms are inherited mainly as autosomal recessive traits, for which 16 genes are currently known. Mutations in the genes encoding connexins 26 and 30 account for up to 50% of these cases. However, the individual contribution of the remaining genes to the whole remains undetermined. In addition, for most of the genes there is a need for studies on genotype-phenotype correlations, to identify distinctive clinical features which may direct the molecular diagnosis to specific genes. Here we present a mutation analysis and a genotype-phenotype correlation study on the gene encoding otoferlin (OTOF), responsible for the DFNB9 subtype of prelingual hearing impairment. Four novel mutations were identified: c.2122C>T (p.Arg708Ter), c.4275G>A (p.Trp1425Ter), c.4362+2T>G, and c.5860_5862delATC (p.Ile1954del). A total of 37 subjects with mutations in OTOF were studied clinically. They were phenotypically homogeneous, having profound hearing impairment with very early onset, as shown by pure-tone audiometry and auditory brainstem responses. Magnetic resonance imaging and computed tomography did not reveal any inner ear malformation. Unexpectedly, transient evoked otoacoustic emissions (TEOAEs) were present, either bilaterally or unilaterally in 11 subjects. Altogether, clinical data of these subjects met the diagnostic criteria of auditory neuropathy. A total of 10 subjects had been successfully provided with cochlear implants. The results of our study indicate that genetic diagnosis of subjects with auditory neuropathy and profound hearing impairment should be directed to the otoferlin gene. Our data are of concern to universal screening programs which use TEOAEs as the first detection test for hearing impairment in newborns, since this technique may overlook a nonnegligible proportion of cases. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14635104     DOI: 10.1002/humu.10274

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  58 in total

Review 1.  [Diagnosis and therapy of auditory synaptopathy/neuropathy].

Authors:  T Moser; N Strenzke; A Meyer; A Lesinski-Schiedat; T Lenarz; D Beutner; A Foerst; R Lang-Roth; H von Wedel; M Walger; M Gross; A Keilmann; A Limberger; T Steffens; J Strutz
Journal:  HNO       Date:  2006-11       Impact factor: 1.284

2.  OTOF mutations revealed by genetic analysis of hearing loss families including a potential temperature sensitive auditory neuropathy allele.

Authors:  R Varga; M R Avenarius; P M Kelley; B J Keats; C I Berlin; L J Hood; T G Morlet; S M Brashears; A Starr; E S Cohn; R J H Smith; W J Kimberling
Journal:  J Med Genet       Date:  2005-12-21       Impact factor: 6.318

3.  The CAPOS mutation in ATP1A3 alters Na/K-ATPase function and results in auditory neuropathy which has implications for management.

Authors:  Lisbeth Tranebjærg; Nicola Strenzke; Sture Lindholm; Nanna D Rendtorff; Hanne Poulsen; Himanshu Khandelia; Wojciech Kopec; Troels J Brünnich Lyngbye; Christian Hamel; Cecile Delettre; Beatrice Bocquet; Michael Bille; Hanne H Owen; Toke Bek; Hanne Jensen; Karen Østergaard; Claes Möller; Linda Luxon; Lucinda Carr; Louise Wilson; Kaukab Rajput; Tony Sirimanna; Katherine Harrop-Griffiths; Shamima Rahman; Barbara Vona; Julia Doll; Thomas Haaf; Oliver Bartsch; Hendrik Rosewich; Tobias Moser; Maria Bitner-Glindzicz
Journal:  Hum Genet       Date:  2018-01-05       Impact factor: 4.132

4.  AUNX1, a novel locus responsible for X linked recessive auditory and peripheral neuropathy, maps to Xq23-27.3.

Authors:  Q J Wang; Q Z Li; S Q Rao; K Lee; X S Huang; W Y Yang; S Q Zhai; W W Guo; Y F Guo; N Yu; Y L Zhao; H Yuan; J Guan; S M Leal; D Y Han; Y Shen
Journal:  J Med Genet       Date:  2006-07       Impact factor: 6.318

5.  What's hot about otoferlin.

Authors:  Karen B Avraham
Journal:  EMBO J       Date:  2016-11-07       Impact factor: 11.598

Review 6.  Function and expression pattern of nonsyndromic deafness genes.

Authors:  Nele Hilgert; Richard J H Smith; Guy Van Camp
Journal:  Curr Mol Med       Date:  2009-06       Impact factor: 2.222

7.  Impairment of SLC17A8 encoding vesicular glutamate transporter-3, VGLUT3, underlies nonsyndromic deafness DFNA25 and inner hair cell dysfunction in null mice.

Authors:  Jérôme Ruel; Sarah Emery; Régis Nouvian; Tiphaine Bersot; Bénédicte Amilhon; Jana M Van Rybroek; Guy Rebillard; Marc Lenoir; Michel Eybalin; Benjamin Delprat; Theru A Sivakumaran; Bruno Giros; Salah El Mestikawy; Tobias Moser; Richard J H Smith; Marci M Lesperance; Jean-Luc Puel
Journal:  Am J Hum Genet       Date:  2008-08       Impact factor: 11.025

8.  Nonsense mutation in TMEM126A causing autosomal recessive optic atrophy and auditory neuropathy.

Authors:  Esther Meyer; Michel Michaelides; Louise J Tee; Anthony G Robson; Fatimah Rahman; Shanaz Pasha; Linda M Luxon; Anthony T Moore; Eamonn R Maher
Journal:  Mol Vis       Date:  2010-04-13       Impact factor: 2.367

9.  Identification of the hair cell soma-1 antigen, HCS-1, as otoferlin.

Authors:  Richard J Goodyear; P Kevin Legan; Jeffrey R Christiansen; Bei Xia; Julia Korchagina; Jonathan E Gale; Mark E Warchol; Jeffrey T Corwin; Guy P Richardson
Journal:  J Assoc Res Otolaryngol       Date:  2010-08-31

10.  Ca2+-binding protein 2 inhibits Ca2+-channel inactivation in mouse inner hair cells.

Authors:  Maria Magdalena Picher; Anna Gehrt; Sandra Meese; Aleksandra Ivanovic; Friederike Predoehl; SangYong Jung; Isabelle Schrauwen; Alberto Giulio Dragonetti; Roberto Colombo; Guy Van Camp; Nicola Strenzke; Tobias Moser
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.